AR and prostate cancer: We observed maximal stimulation of cell proliferation and inhibition of apoptosis in response to genistein in LNCaP cells at a dose of 1μmol/L, indicating that apparently modest exposure to the phytoestrogen genistein can have significant adverse biological consequences for prostate cancers that carry promiscuously mutant AR.